Table 2 Demographic information of patients with P. aeruginosa isolates (N = 70) in different hospitals.

From: Synergistic effects of meropenem, amikacin, and ciprofloxacin against carbapenem resistant Pseudomonas aeruginosa isolates

Variables

Hospitals

Namazi

N = 38 (%)

Rajaee

N = 20 (%)

Amir

N = 12 (%)

Total

N = 70 (%)

Male Gender

23 (60.5%)

12 (60%)

10 (83.3%)

45 (64.3%)

Specimens

Blood

6 (15.8%)

2 (10%)

9 (75%)

17 (24.3%)

Urine

6 (15.8%)

4 (20%)

1 (8.3%)

11 (15.7%)

Sputum

7 (18.5%)

6 (30%)

1 (8.3%)

14 (20%)

Wound

8 (21.1%)

4 (20%)

0

12 (17.1%)

Tissue

3 (7.9%)

0

1 (8.3%)

4 (5.7%)

Axillary

1 (2.6%)

0

0

1 (1.4%)

Pleural

1 (2.6%)

0

0

1 (1.4%)

Vaginal discharge

5 (13.2%)

0

0

5 (7.1%)

ETT

1 (2.6%)

4 (20%)

0

5 (7.1%)

Wards

ICU

13 (34.2%)

7 (35%)

4 (33.3%)

24 (34.3%)

Emergency

14 (36.8%)

3 (15%)

3 (25%)

20 (28.6%)

Pediatrics

4 (10.5%)

3 (15%)

3 (25%)

10 (14.3%)

Internal Medicine

2 (5.3%)

4 (20%)

2 (16.7%)

8 (11.4%)

Surgery

5 (13.2%)

3 (15%)

0

8 (11.4%)

  1. ICU, Intensive Care Unit; ETT, endotracheal tube.
Back to article page